AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Mar 03 2022
Headline Roundup
Sacklers Agree to $6 Billion Opioid Settlement With US States
The Sackler family owners of Purdue Pharma agreed Thursday to pay as much as $6 billion to resolve thousands of opioid lawsuits from several states.
The agreement, which has yet to be approved by a bankruptcy judge, came after Purdue and several states traded appeals on a previous bankruptcy agreement involving a $4.5 billion payout. The new deal would not protect the Sacklers from
Wall Street Journal (News) New York Times (News) New York Post (News)Jul 31 2020
Headline Roundup
Coronavirus Vaccine Slowly Coming Into Focus
Dr. Anthony Fauci told a House of Representatives committee Friday that a COVID-19 coronavirus vaccine would likely be created by the end of the year, and widely distributed to Americans in 2021.
Some voices examined how people who oppose the use of vaccines may react when the coronavirus treatment is distributed to the masses; others focused on the billions of dollars the U.S. is
The Hill MarketWatch The AtlanticMay 15 2020
Headline Roundup
Virus Testing is up Overall, but Some States May be Falling Behind
Conflicting headlines and different reporting angles have helped fuel confusion around the status of COVID-19 coronavirus testing in the United States, and whether or not the country is performing tests adequately, or if it's falling short.
Some outlets are focusing on the recent overall increase in daily tests conducted in the U.S., while others are singling out certain states and
Associated Press New York Post (News) VoxApr 07 2020
Headline Roundup
Trump's Small Financial Stake in Hydroxychloroquine Maker
On Monday, the New York Times reported that President Donald Trump has financial ties to a company that manufactures the anti-malaria drug hydroxychloroquine, which the president has said could be a potential treatment for the COVID-19 coronavirus. There is no known cure for COVID-19.
Most outlets, regardless of rating, reported that the president's stake in Sanofi is relatively small,
Raw Story Forbes MarketWatchMar 26 2020
Headline Roundup
Amid Coronavirus Pandemic, Good News is Still Available
Good things are still happening, both on the coronavirus front and entirely separate from it, as humanity continues to grapple with a global pandemic that's infected nearly 500,000 people worldwide. Coverage from news organizations throughout the political spectrum is managing to maintain a positive element, as scientists fight to find a cure and people work to maintain community and
Bloomberg Fox News (Online News) BuzzFeed NewsMar 23 2020
Headline Roundup
Partisan Divide in Coverage of Potential Coronavirus Treatments
Media coverage of the race to find a coronavirus cure has often divided along partisan lines. There are no drugs currently approved to prevent or treat the coronavirus; President Donald Trump recently stated that two specific drugs used in anti-malaria medications — chloroquine and hydroxychloroquine — may eventually provide a base for a coronavirus treatment, which the left and right sides of
BuzzFeed News Wall Street Journal (News) Daily MailFeb 27 2020
Headline Roundup
Stock Market in Historic Slide as Coronavirus Fears Escalate
All three major U.S. stock indexes — the Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite — suffered their largest one-day losses in history Thursday, as the global economy continued to slide over coronavirus fears. The six-day drop for stocks persisted after President Donald Trump put Vice President Mike Pence in charge of the U.S. response to the virus Wednesday
Wall Street Journal (News) MarketWatch Yahoo NewsOct 24 2021
Headline Roundup
FDA Says Benefits Of Pfizer's COVID-19 Vaccine Outweigh Risks In Children 5 To 11
Food and Drug Administration regulators shared a study on Friday that said the benefits of the Pfizer-BioNTech vaccine for children ages 5 to 11 “would clearly outweigh” any serious side effects. On the same day, the FDA posted data from Pfizer and BioNTech that showed their vaccine had a 90.7% efficacy rate in preventing symptomatic COVID-19 infections in a clinical trial of 5-to 11-year-olds
Axios New York Post (News) New York Times (News)Oct 07 2021
Headline Roundup
Pfizer Requests FDA Vaccine Authorization for Children 5 to 11
Pfizer and BioNTech announced Thursday that they had formally requested FDA emergency use authorization of their COVID-19 vaccine for children ages 5 to 11. The request comes roughly three weeks after Pfizer said a lower vaccine dose had proven safe and effective in clinical trials for that age group. The FDA has scheduled a meeting of its advisory board for Oct. 26 to consider the
New York Times (News) NPR (Online News) Fox News (Online News)Feb 08 2023
Headline Roundup
Fact Checking Biden's 2023 State of the Union Address
President Joe Biden made several statements during Tuesday night's State of the Union that sparked clarifications from fact checkers across the political spectrum.
Job Growth: Biden said he created "more jobs created in two years than any president has ever created in four years." The raw number is accurate. However, Biden left out the fact that job growth was sparked by post-COVID-19
The Daily Caller CNN Fact Check FactCheck.org